drugset / Trial / NCT03149445
Co-administration of Tesofensine/Metoprolol in Subjects With Prader-Willi Syndrome (PWS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Two-centre, double-blind, placebo-controlled, randomized, and multiple-dose clinical study followed by two open label extension periods.
Timeline
- Start
- 2017-03-30
- Primary completion
- 2019-07-22
- Completion
- 2019-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metoprolol | Other / unclassified | — | — |
| Subject | Tesofensine | Small molecule | — | — |